Comparison between Concord Enviro Systems IPO and Senores Pharmaceuticals IPO.
Concord Enviro Systems IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Senores Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Enviro Systems IPO is up to ₹500.33 Cr whereas the issue size of the Senores Pharmaceuticals IPO is up to ₹582.11 Cr. The final issue price of Concord Enviro Systems IPO is ₹701.00 per share and of Senores Pharmaceuticals IPO is ₹391.00 per share.
| Concord Enviro Systems IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹665.00 per share | ₹372.00 per share |
| Issue Price (Upper) | ₹701.00 per share | ₹391.00 per share |
| Issue Price (Final) | ₹701.00 per share | ₹391.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 21 shares | 38 shares |
| Fresh Issue Size | 24,96,433 shares | 1,27,87,723 shares |
| Fresh Issue Size (Amount) | up to ₹175.00 Cr | up to ₹500.00 Cr |
| OFS Issue Size | 46,40,888 shares | 21,00,000 shares |
| OFS Issue Size (Amount) | up to ₹325.33 Cr | up to ₹82.11 Cr |
| Issue Size Total | 71,37,321 shares | 1,48,87,723 shares |
| Issue Size Total (Amount) | up to ₹500.33 Cr | up to ₹582.11 Cr |
Concord Enviro Systems IPO opens on Dec 19, 2024, while Senores Pharmaceuticals IPO opens on Dec 20, 2024. The closing date of Concord Enviro Systems IPO and Senores Pharmaceuticals IPO is Dec 23, 2024, and Dec 24, 2024, respectively.
| Concord Enviro Systems IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Dec 18, 2024 | Dec 19, 2024 |
| Issue Open | Dec 19, 2024 | Dec 20, 2024 |
| Issue Close | Dec 23, 2024 | Dec 24, 2024 |
| Basis Of Allotment (Tentative) | Dec 24, 2024 | Dec 26, 2024 |
| Initiation of Refunds (Tentative) | Dec 26, 2024 | Dec 27, 2024 |
| Credit of Share (Tentative) | Dec 26, 2024 | Dec 27, 2024 |
| Listing date (Tentative) | Dec 27, 2024 | Dec 30, 2024 |
| Anchor Lockin End date 1 | Jan 22, 2025 | Jan 24, 2025 |
| Anchor Lockin End date 2 | Mar 23, 2025 | Mar 25, 2025 |
Concord Enviro Systems IPO P/E ratio is 30.79, as compared to Senores Pharmaceuticals IPO P/E ratio of 39.77.
| Concord Enviro Systems IPO | Senores Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 60.93 | 66.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 51.39 | 45.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 30.79 | 39.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1450.81 Cr. | ₹1350.70 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 13.73% | 23.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.07% | 11.73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.47 | 1.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹22.77 | ₹9.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 12.92% | 23.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Enviro Systems IPO Retail Individual Investors (RII) are offered 24,98,063 shares while in Senores Pharmaceuticals IPO retail investors are offered 24,98,063 shares. Qualified Institutional Buyers (QIB) are offered 14,27,464 shares in Concord Enviro Systems IPO and 44,43,818 shares in Senores Pharmaceuticals IPO.
| Concord Enviro Systems IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 21,41,195 shares | 66,65,725 shares |
| Market Maker Reservation | ||
| QIB | 14,27,464 shares | 44,43,818 shares |
| NII | 10,70,599 shares | 22,21,908 shares |
| RII | 24,98,063 shares | 14,81,272 shares |
| Employee | 75,000 shares | |
| Others | ||
| Total | 71,37,321 shares | 1,48,87,723 shares |
Concord Enviro Systems IPO subscribed 10.67x in total, whereas Senores Pharmaceuticals IPO subscribed 97.86x.
| Concord Enviro Systems IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 17.32x | 97.84x |
| NII (times) | 14.20x | 100.35x |
| Big NII (times) | 14.09x | 95.25x |
| Small NII (times) | 14.41x | 111.35x |
| RII (times) | 5.56x | 93.16x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 10.67x | 97.86x |
